On November 2, 2026, Unilever introduced plans for a Surf Excel Matic Liquid laundry detergent in India containing an AI-designed enzyme developed with protein-design company Arzeda. The announcement concerns how a new technology enters a specific laundry product. It still describes the product as forthcoming and gives no firm launch date.

According to Unilever, the enzyme was designed around three objectives: cleaning, fabric care and lasting fragrance. The company also notes that a naturally occurring enzyme's capabilities do not automatically deliver the desired result in real washing conditions. A candidate that looks promising in the laboratory still needs to be assessed on fabric and in actual washes. AI helps select designs worth testing further, rather than removing the need for subsequent experiments.

In its home and personal care business overview, Arzeda connects protein design, strain engineering, bioprocess development and enzyme manufacturing, emphasising development for specific formulations, wash processes and changing conditions of use. For laundry-liquid development, this extends the focus from finding a candidate enzyme to making the candidate fit the product: the design needs to work with the actual formulation and its use environment.

The collaboration has a longer research history. In a progress report published on June 12, 2023, Unilever explained that the companies had worked together since July 2021, with Arzeda responsible for enzyme design, strain engineering and initial scale-up. Quantities for real-world testing had been produced at that stage, while further production scale-up continued. From historical research progress to a new product launch plan, design, testing, production scale-up and market introduction are connected but distinct milestones.

On November 3, Unilever separately announced plans for an additional EUR 35 million investment in its Indian R&D capabilities, upgrading its Mumbai and Bangalore centres. This includes EUR 5 million over the next five years for a strategic Bio-Futures partnership. The company aims to connect consumer insight, scientific discovery, prototyping and scale-up more closely. These are further development plans for its R&D system and should be distinguished from the laundry-liquid plans announced the previous day.

On a separate industrial-enzyme research track, Fraunhofer IZI-BB also presented the ZenBio project on November 2. The team combines cell-free protein synthesis, automated experiments and AI-assisted design: cell extracts are used to produce enzyme variants, generating data on the relationship between sequence changes and functional performance. The research explores more systematic ways to generate experimental data and base the next design round on measured results.

Fraunhofer says the team has implemented the first phase of its automated workflow. Further miniaturisation, automation and validation using an initial enzyme class are next steps. Pilot projects with industrial customers and the proposed company ProEvo also remain future plans. This separate project concerns progress in platform development, not the commercial launch of a laundry liquid or validation of Unilever's product performance.

For home-care development teams, the point of interest is not only what designs AI generates, but also how candidates move into experiments, formulations and manufacturing, and what each stage needs to resolve. A specific project can begin with the product category, intended use, target market and packaging requirements, followed by discussions of samples and production. For an overview of these discussions, see the existing home and personal care OEM/ODM service information on the Yipinjing website.

A blue whale character wearing round glasses reads an open booklet
A blue whale character reads a booklet. Enzyme design, formulation testing and commercial launch are different development stages; the illustration is not a laboratory or product photograph.